Atlas Trials

Study of BAY1834942 in Patients With Solid Tumors

Clinical trial NCT03596372 · COMPLETED

Trial details

NCT number
NCT03596372
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced CEACAM6-expressing Solid Tumors
Start date
2018-06-19
Primary completion
2020-11-16
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.